HomeAPTOF • OTCMKTS
add
Aptose Biosciences Inc
Previous close
$2.12
Day range
$2.20 - $2.23
Year range
$1.10 - $38.10
Market cap
5.62M USD
Avg Volume
41.36K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.19M | -81.97% |
Net income | -1.58M | 86.74% |
Net profit margin | — | — |
Earnings per share | -34.90 | 19.21% |
EBITDA | -2.18M | 81.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.15M | -33.51% |
Total assets | 10.13M | -22.03% |
Total liabilities | 14.67M | -7.68% |
Total equity | -4.54M | — |
Shares outstanding | 2.55M | — |
Price to book | -0.94 | — |
Return on assets | -51.93% | — |
Return on capital | -142.33% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.58M | 86.74% |
Cash from operations | -8.06M | 12.95% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 6.80M | 696.84% |
Net change in cash | -1.26M | 80.60% |
Free cash flow | -7.76M | -59.69% |
About
Founded
1986
Headquarters
Website
Employees
13
